Cited by 66Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatmentsBarrier Structure and Function Studies

Monocyte-derived cells invade brain parenchyma and amyloid plaques in human Alzheimer’s disease hippocampus

Open access
Muñoz-Castro, Clara, Mejias-Ortega, Marina, Sanchez-Mejias, Elisabeth, Navarro, Victoria, Trujillo-Estrada, Laura, Jimenez, Sebastian, Garcia-Leon, Juan Antonio, Fernandez-Valenzuela, Juan Jose +7 more·2023·Acta Neuropathologica Communications

Abstract

Microglia are brain-resident myeloid cells and play a major role in the innate immune responses of the CNS and the pathogenesis of Alzheimer's disease (AD). However, the contribution of nonparenchymal or brain-infiltrated myeloid cells to disease progression remains to be demonstrated. Here, we show that monocyte-derived cells (MDC) invade brain parenchyma in advanced stages of AD continuum using transcriptional analysis and immunohistochemical characterization in post-mortem human hippocampus. Our findings demonstrated that a high proportion (60%) of demented Braak V–VI individuals was associated with up-regulation of genes rarely expressed by microglial cells and abundant in monocytes, among which stands the membrane-bound scavenger receptor for haptoglobin/hemoglobin complexes or Cd163. These Cd163-positive MDC invaded the hippocampal parenchyma, acquired a microglial-like morphology, and were located in close proximity to blood vessels. Moreover, and most interesting, these invading monocytes infiltrated the nearby amyloid plaques contributing to plaque-associated myeloid cell heterogeneity. However, in aged-matched control individuals with hippocampal amyloid pathology, no signs of MDC brain infiltration or plaque invasion were found. The previously reported microglial degeneration/dysfunction in AD hippocampus could be a key pathological factor inducing MDC recruitment. Our data suggest a clear association between MDC infiltration and endothelial activation which in turn may contribute to damage of the blood brain barrier integrity. The recruitment of monocytes could be a consequence rather than the cause of the severity of the disease. Whether monocyte infiltration is beneficial or detrimental to AD pathology remains to be fully elucidated. These findings open the opportunity to design targeted therapies, not only for microglia but also for the peripheral immune cell population to modulate amyloid pathology and provide a better understanding of the immunological mechanisms underlying the progression of AD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s40478-023-01530-z

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Postmortem AD brain tissues show extensive monocyte infiltration into the brain parenchyma, where monocytes cluster around amyloid-β plaques.

    “End point analyses of postmortem AD brain tissues show extensive monocyte infiltration into the brain parenchyma of patients with AD, where they cluster around amyloid-β (Aβ) plaques (13, 14).”

    From Understanding monocyte-driven neuroinflammation in Alzheimer’s disease using human cortical organoid microphysiological systems (2025) · cites this paper as [13]

    The Discussion (page not provided) reports monocyte infiltration into AD hippocampal parenchyma and an association of CD163-positive cells with amyloid-β plaques. It does not support describing infiltration as extensive across AD brains: the authors call the population small, report substantial variation between patients, and note that some AD cases had little or no infiltration. (LLM, conf=0.90)

    Experimental — accuracy not yet measured
  • Activated microglia and infiltrating monocytes are detectable in the early stages of AD.

    “Given that activated microglia and infiltrating monocytes are detectable in the early stages of AD [27], basal over-activation of innate immune cells in females could be a potential link to the increased prevalence of AD in women.”

    From Alzheimer’s disease-associated protective variant Plcg2-P522R modulates peripheral macrophage function in a sex-dimorphic manner (2024) · cites this paper as [27]

    The Results section on parenchymal and plaque-associated CD163 cells reports activated microglia at plaques in early Braak II cases, but no infiltrating CD163-positive cells in those cases’ hippocampal parenchyma. The Discussion notes high monocyte-infiltration levels in some non-demented Braak II or III–IV cases, while saying infiltration was predominantly found in advanced AD and might reflect other comorbidities. The source therefore does not support presenting both cell populations as generally detectable in early AD. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • AD monocytes colocalize with Aβ in hCO-MPSs.

    “AD monocytes also colocalized with Aβ in the hCO-MPSs (Fig. 2C), supporting the previous observations that infiltrated monocytes accumulate around Aβ plaques in the brain tissues of patients with AD (13).”
  • The population of infiltrated monocytes increases as AD progression worsens.

    “The population of infiltrated monocytes was also found to increase as the AD progression worsens (13).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 68 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Muñoz-Castro, C., Mejias-Ortega, M., Sanchez-Mejias, E., Navarro, V., Trujillo-Estrada, L., Jimenez, S., Garcia-Leon, J. A., Fernandez-Valenzuela, J. J., Sanchez-Mico, M. V., Romero-Molina, C., Moreno-Gonzalez, I., Baglietto-Vargas, D., Vizuete, M., Gutierrez, A., & Vitorica, J.
Affiliations
Biomedical Research Networking Center on Neurodegenerative Diseases (ES)
Venue
Acta Neuropathologica Communications
Published
2023-02-28
Volume
11
Issue
1
Pages
31-31
ISSN
2051-5960 (ISSN-L)
OpenAlex
W4322621114
Cited by
66
References
68
Citations by year
2026: 19 · 2025: 25 · 2024: 17 · 2023: 5
FWCI
6.80
Type
journal article
Language
en
Open access
Locations
  • Acta Neuropathologica Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, cc-by)
  • Repositorio Institucional de la Universidad de Málaga (University of Málaga) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Deposito de Investigacion Universidad de Sevilla (University of Seville) (submittedVersion, cc-by-nc-nd)
Funders
  • Instituto de Salud Carlos III (PI18/01556, PI21/00914, PI18/01557, PI21/00915)
  • Consejería de Economía, Innovación, Ciencia y Empleo, Junta de Andalucía (US-1262734)
  • Consejería de Economía, Conocimiento, Empresas y Universidad, Junta de Andalucía (P20-00843, UMA18-FEDERJA-211, PI18-RT-2233)
  • Ministerio de Ciencia, Innovación y Universidades (PID2019-108911RA-100, PID2019-107090RA-I00)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Keywords
Alzheimer's disease, monocyte-derived cells, microglia, hippocampus, amyloid plaques, CD163, endothelial activation, blood-brain barrier, myeloid cell heterogeneity, Braak stages, postmortem brain
MeSH terms
Aged, Alzheimer Disease, Brain, Hippocampus, Humans, Monocytes, Plaque, Amyloid, Amyloidogenic Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review